The company
The Efferon company develops devices with polymer sorbents that help purify the blood during severe conditions of patients with COVID-19.
The funding
Efferon, based in Villach, Austria, announced €2.5M in Seed financing on May 21, 2026.
Efferon Raises €2.5M Seed
Efferon raised €2.5M in a Seed round announced on May 21, 2026. The Efferon company develops devices with polymer sorbents that help purify the blood during severe conditions of patients with COVID-19.
Round size
€2.5MStage
SeedHeadquarters
AustriaAnnounced
May 21, 202603 / Related rounds
Related funding rounds
Growth · Healthtech
Uromems
UroMems is a medical device company developing smart active implantable technology to treat stress urinary incontinence in women and men.